Regulatory Interactions and Learnings— RADIAL the Trials@Home Proof‐of‐Concept Trial on Decentralization
Clinical Pharmacology & Therapeutics · 2025
DOI: 10.1002/cpt.70078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2025. Verfasst von Helga Gardarsdottir und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrec…. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Proof of Concept Study. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This paper is part of a series of six publications presenting lessons learned during the setup, regulatory submission, and conduct of the proof‐of‐concept Trials@Home RADIAL trial. The three‐arm RADIAL trial, comprising fully decentralized, hybrid, and conventional arms, is the first clinical study to evaluate the feasibility and acceptability of decentralized clinical trial elements across six European countries. In this paper, insights from multiple formal regulatory interactions related to the RADIAL trial, conducted between 2021 and 2022, are presented. These interactions included (i) a consultation with the European Medicines Agency’s Innovation Task Force, (ii) a national Scientific Advice procedure, and (iii) the clinical trial application submission under the EU Clinical Trials Regulation (Regulation EU 536/2014). Given the novelty of the decentralized approach and lack of guidelines, many constructive comments and questions were received that supported the finalization of the protocol and conduct of the trial. It is important to acknowledge that clinical trials often span multiple countries and regulatory jurisdictions, creating complexity due to variations in complementary national legal and regulatory requirements. We conclude that early and continuous regulatory engagement is essential for the successful implementation of innovative trial designs. Although progress has been made in supporting decentralized clinical trials, persistent challenges related to legislative heterogeneity remain. Harmonized regulatory guidance and greater transparency through the sharing of regulatory experiences will be key to facilitating the broader adoption of decentralized approaches and advancing clinical trials in Europe.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.
- Department of Pharmaceutical Sciences, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
- Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands.
- UCB Biopharma, Brussels, Belgium.
- Global Regulatory Sciences, Pfizer R&D UK Limited, Kent, UK.
- Fortrea Development Ltd UK, Leeds, UK.
ORCID-Profile: Helga Gardarsdottir, Hamidou Traore, Kate Huntley, Amos J de Jong, Megan Heath, Bart Lagerwaard, Mira G P Zuidgeest
Zitieren
APA
Gardarsdottir, H., Traore, H., Huntley, K., Mistry, D., de Jong, A. J., Legathe, A., de Smedt, T., Askin, S., Heath, M., Corriol-Rohou, S., Lagerwaard, B., Zuidgeest, M. G. P., & IMI Trials@Home Consortium (2025). Regulatory Interactions and Learnings— RADIAL the Trials@Home Proof‐of‐Concept Trial on Decentralization. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70078
Vancouver
Gardarsdottir H, Traore H, Huntley K, Mistry D, de Jong AJ, Legathe A, et al. Regulatory Interactions and Learnings— RADIAL the Trials@Home Proof‐of‐Concept Trial on Decentralization. Clinical Pharmacology & Therapeutics. 2025. doi:10.1002/cpt.70078
BibTeX
@article{Gardarsdottir2025,
author = {Gardarsdottir, Helga and Traore, Hamidou and Huntley, Kate and Mistry, Dinesh and de Jong, Amos J and Legathe, Agnes and de Smedt, Tim and Askin, Scott and Heath, Megan and Corriol-Rohou, Solange and Lagerwaard, Bart and Zuidgeest, Mira G P and IMI Trials@Home Consortium, IMI Trials@Home Consortium},
title = {Regulatory Interactions and Learnings— RADIAL the Trials@Home Proof‐of‐Concept Trial on Decentralization},
journal = {Clinical Pharmacology & Therapeutics},
year = {2025},
doi = {10.1002/cpt.70078}
}
EUVIMED